Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Illness01:17

Classification of Illness

9.3K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum interleukin-2 levels associate with disease activity and cardiovascular risk in patients with rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same author

Measles vaccination status and evidence of immunity among medical students in Catalonia (Spain), 2023-2025: a cross-sectional study.

BMC medical education·2026
Same author

Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression.

PloS one·2026
Same author

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

International journal of molecular sciences·2026
Same author

iDeepLC: Chemical Structure Information Yields Improved Retention Time Prediction of Peptides with Unseen Modifications.

Analytical chemistry·2026
Same author

A silicon microneedle array atmospheric pressure plasma ionization source for real-time trace gas chemical analysis.

Microsystems & nanoengineering·2026

Related Experiment Video

Updated: Mar 30, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K

Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.

Eva Borràs1, Ester Cantó2, Meena Choi3

  • 1From the ‡Proteomics Unit, Centre de Regulació Genòmica (CRG), Dr. Aiguader 88, 08003 Barcelona, Spain; §Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, 08003 Barcelona, Spain;

Molecular & Cellular Proteomics : MCP
|November 11, 2015
PubMed
Summary

A new diagnostic test using targeted mass spectrometry can predict multiple sclerosis (MS) development from clinically isolated syndrome (CIS). This test identifies patients at high risk, enabling earlier treatment to prevent MS progression and brain damage.

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Related Experiment Videos

Last Updated: Mar 30, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.5K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Area of Science:

  • Neurology
  • Biochemistry
  • Immunology

Background:

  • Multiple sclerosis (MS) is a central nervous system inflammatory, demyelinating, and neurodegenerative disease.
  • Clinically isolated syndrome (CIS) is the initial neurological event for most MS patients, but conversion to MS is uncertain.
  • Current diagnostic methods lack definitive tests to predict MS development from CIS.

Purpose of the Study:

  • To develop a sensitive and specific diagnostic molecular classifier for predicting MS development from CIS.
  • To differentiate between CIS patients with high and low risk of converting to clinically defined MS.
  • To aid in early diagnosis and treatment initiation for MS.

Main Methods:

  • Utilized targeted mass spectrometry for protein abundance analysis in cerebrospinal fluid.
  • Identified and quantified specific protein biomarkers, including chitinase 3-like 1 and ala-β-his-dipeptidase.
  • Developed a statistical model to calculate the probability of conversion from CIS to MS.

Main Results:

  • Established a diagnostic molecular classifier with high sensitivity and specificity.
  • The classifier accurately differentiates CIS patients based on their risk of developing MS.
  • The model provides a precise probability of conversion to clinically defined MS using protein biomarkers.

Conclusions:

  • The developed classifier offers a reliable method for early MS risk assessment in CIS patients.
  • Early identification of high-risk individuals allows for timely therapeutic intervention.
  • This approach has the potential to significantly improve MS management by preventing irreversible brain damage and slowing disease progression.